A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight

NCT05929079 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

1000

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes
Obesity
Overweight
Obstructive Sleep Apnea

Interventions

DRUG: Retatrutide
DRUG: Placebo

Sponsor

Eli Lilly and Company